Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

One very influential set of guidelines — viewed more than 50 million times and used by doctors around the world — is the COVID-19 Treatment Guidelines from the National Institutes of Health (NIH).

“Some people think that if they got the vaccine or feel healthy, they don’t need treatment,” said Karyne Jones, President and CEO of NCBA, Inc. and co-convener of CVEEP. “But that’s not always true.

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

COVID-19 is caused by the SARS-CoV-2 virus. This image shows antibodies (shown in orange and purple) binding to 'spike proteins' on the surface of SARS-CoV-2 virus (shown in teal and yellow ...

This is a MedPage Today story. As patients with long COVID-19 scour the internet desperate for relief, physicians are concerned they may stumble upon an unproven treatment plan touted by a group ...

A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients. eLife, 2024; 13 DOI: 10.7554/eLife.89801 ...

The treatment of choice for a while In 2020, then-President Donald Trump said he had been taking hydroxychloroquine to prevent a COVID-19 infection, despite warnings by the U.S. Food and Drug ...

An office worker surnamed Lee recently experienced high fever, chills, and muscle pain. At first, Lee thought it was just a summer cold or air conditioning sickness and took cold medicine. But ...

The treatment of lab-created monoclonal antibodies is meant to be used in the early stages of infection, to help patients -- those at high-risk for severe illness -- recover from COVID-19.